Osmetech, the international diagnostics group, has appointed Bruce Huebner as President of its recently acquired molecular diagnostics business, Clinical Micro Sensors, Inc (“CMS”).

Bruce has over 32 years of sales, marketing and management experience in the healthcare industry with significant experience in the molecular diagnostics and infectious diseases market sectors. Most recently he was President and Chief Operating Officer of Nanogen, Inc, a nanotechnology micro-array company operating in similar markets to CMS. Prior to that Bruce was Executive Vice President and Chief Operating Officer of Gen-Probe, Inc., a biotech diagnostics company with a strong market position in infectious diseases, having previously been Vice President of Marketing and Sales

James White, Osmetech Chief Executive, said:

‘Bruce’s considerable experience and leadership skills will be invaluable in driving the CMS business through to commercialization. He has a strong record of success in sales and marketing in addition to his general management achievements with other diagnostics companies at important stages in their development and growth.

‘Bruce and his team at CMS will work closely with our OPTI GENE group to ensure that that the considerable opportunities for Osmetech’s emerging molecular diagnostics businesses are fully realised.’